Goldman Sachs’s Sight Sciences SGHT Stock Holding History
Bought
Maintained
Sold
Other funds holding SGHT
LFCM
AP
VCM
BGI
Goldman Sachs's SGHT Position: Q1 2026 in Review
Goldman Sachs reduced its Sight Sciences (SGHT) stake by 20% in Q1 2026, selling an estimated $174K and leaving 126,390 shares worth $476K. The position accounts for ﹤0.01% of the portfolio, ranked #5630.
Goldman Sachs first reported a position in SGHT in Q3 2021 and has held it in 14 quarters since. The position peaked at $1.71M in Q2 2022. 114 funds tracked by Wall St. Rank hold SGHT as of Q1 2026.
- Goldman Sachs held 126,390 shares of Sight Sciences worth $476K as of Q1 2026.
- Goldman Sachs sold 32,253 Sight Sciences shares in Q1 2026, an estimated $174K.
- Sight Sciences made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #5630 holding.
- Goldman Sachs first reported a position in Sight Sciences in Q3 2021 and has held it in 14 quarters since.
- Goldman Sachs's Sight Sciences position peaked at $1.71M in Q2 2022.
- 114 funds tracked by Wall St. Rank held Sight Sciences as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.